Project plans of EUnetHTA reports to be published in 2018

EUnetHTA is a network of HTA bodies within Europe that promote the development of health technology assessment in all European countries by working together. This article will present the plans for the projects that will be published in the near future.

OTCA14 “Robotic surgery in thoracic and visceral indications” – plan published on 11th of July, 2018

• Project done by: Austrian Ludwig Boltzmann Institue (LBI-HTA) and Italian Veneto Region (Azienda Zero)
• Objectives: a rapid HTA in order to assess whether robot-assisted surgery in patients with an indication for surgery in the area of the thorax and viscera (abdomen) is more effective and safer (or at least as safe) than laparoscopic or open surgery (or thoracoscopic approach for thoracic surgery)
• Method: a systematic review; literature searched on Embase, Medline, CRD database, Cochrane Library
• Manufacturer commenting on the assessment: Intuitive Surgical
• Expected date of the publication of the report: 30th of November 2018
• Link to the detailed plan in English can be found here

OTJA10 “Stool DNA testing for early detection of colorectal cancer” – plan published on 25th of July, 2018

• Project done by: Austrian Public Health Institute, Slovenian Public Health Institute, Slovenian Agency for Medical Products and Devices
• Objectives: a rapid HTA in order to assess whether Stool DNA testing (alone or in addition to occult blood testing) in adult patients from a colorectal cancer screening population is more effective and/or safer than other available colorectal cancer screening tests
• Method: a systematic review; literature searched on Embase, Medline, Cochrane Library, ClinicalTrials.gov, International Clinical Trials Registry Platform (ICTRP) and the EU Clinical Trials Register
• Manufacturers commenting on the assessment: PharmGenomics GmbH, Exact Sciences Corp.
• Expected date of the publication of the report: 25th of March 2019
• Link to the detailed plan in English can be found here

OTCA16 Bioresorbable Stents in cardiovascular indications (coronary artery disease) – plan published on 21st of August, 2018

• Project done by: Institute for General Practice and Evidence-based Health Service Research (IAMEV), Medical University of Graz, Austria and National School of Public Health, Management and Professional Development Bucharest (SNSPMPDSB), Romania
• Objectives:  a rapid HTA  in order to assess the question whether percutaneous coronary intervention (PCI) with implantation of a fully bioabsorbable/biodegradable/bioresorbable vascular scaffold/stent (BVS) in adult patients with coronary artery disease (CAD) including stable angina, unstable angina, myocardial infarction (ICD-10 code I20-I25) who require and are eligible for myocardial revascularization is more effective and/or safer than PCI with implantation of other stent types or other revascularisation strategies
• Method: a systematic review; literature searched on PubMed, MEDLINE, EMBASE and Cochrane Central Register of Controlled Trials, Cochrane Database for Systematic Reviews, ClinicalTrials.gov and WHO-ICTRP
• Expected date of the publication of the report: 21st of December 2018
• Link to the detailed plan in English can be found here

Furthermore, you can see the updated list of accomplished and coming EUnetHTA assessments here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.